Published

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Affective Disorders
Date: 2026-11-01
Source: Crossref
DOI: 10.1016/j.jad.2026.122063
PubMed: 42248535

Authors

Kelly Carlton M.Fradet Mathieu Bostian Catherine M.Donnelly Anna Ellis Sara Ostacher Michael Aaronson Scott Suppes Trisha

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Treatment-Resistant Depression Veterans Other

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1177/0269881119897615 10.1016/j.eclinm.2020.100538 10.1177/0269881115609019 10.1177/0269881116678781 10.1002/jts.22975 10.1038/s41398-022-02285-2 10.1016/s2215-0366(16)30065-7 10.1007/s00213-017-4771-x 10.1016/s2215-0366(25)00372-4 10.1001/jamapsychiatry.2020.3285 10.7249/rhq-05-04-13 10.1016/j.jad.2025.119655

Indexed papers citing this DOI

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01

Related papers

A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-08-14 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-09-01 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10